SYN is a Pharmaceutical company based in Athens, focused on medicines- nutritions for chronic, life-threatening and rare diseases, providing one stop shop services for SE European countries for diagnosis, treatment and therapy.
The personnel and the owners have multinational experience and long-term relationships with the health stakeholders and profound capabilities ,with proven efficacy from CxO positions for more than 20 years in SE Europe countries.
Milestones
2015
Distribution agreement with Fresenius-kabi enteral nutrition
2015
Creation of PharmaVision Europe for expansion in South Balkans
countries (Bulgaria ,Albania ,Kosovo) and Cyprus
2015
Launching Lipiodol orphan liver embolization
2015
relaunching Guerbet’s contrast media portofolio in Greece and Cyprus
2014
Submission cyclotron business plan
2014
Initiation of imaging-diagnosis Unit
Mission
Provide patients with high quality, innovative, life changing medicines for diagnosis, treatment and therapy
Vision
SYN shall be the preferred partner, well known, respectful and distinct pharmaceutical company proving high quality medications and innovative products
Values
SYN invests in emotional intelligence, promoting teamwork, highly workgroups and a unique altruistic chemistry
SYN embraces innovation, continuous learning and challenging changes
SYN is recognized by everyone as a company that fulfills its responsibilities contributes towards the society